Seminar Recording · Clinical Research & Training

The Future of 5-MeO-DMT: Numinus x F.I.V.E.

With Payton Nyquvest, Dr. Paul Thielking, Hannah Cross, Joel Brierre & Victoria Wueschner

F.I.V.E. and Numinus explore the future of 5-MeO-DMT: emerging clinical research, safety, practitioner training, integration, ethics and responsible pathways forward.

What you'll learn

  • Why 5-MeO-DMT is a focus of drug development right now, and what early clinical data is showing
  • Risks and adverse events seen in clinical trials
  • Why trained, two-person support matters, including seizure-like movement and injury risk
  • Medical and transformational models of 5-MeO-DMT work, and how they differ
  • Preparation for existential fears, and the integration and ethics the field needs next

Clinical ResearchPractitioner Training

Information shared by seminar speakers does not necessarily represent the views, thoughts, and opinions of The FIVE Institute.